See also this year's filing and all EDGAR filings for this company.
PDF Report 0001690585_2021_Dianthus_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001690585, Dianthus Therapeutics Inc. DE
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 151,527,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 8,312,000 |
3 | remainder_Assets | 1,780,000 |
4 | LiabilitiesCurrent | 11,430,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 6,283,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 28,087,000 |
9 | ResearchAndDevelopmentExpense | 50,615,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 3,766,000 |
12 | remainder_NetIncome | 0 |
13 | remainder_ComprehensiveNetIncome | -31,000 |
yvar | yval | |
---|---|---|
0 | Assets | 161,619,000 |
1 | Liabilities | 17,713,000 |
2 | Expenses | 78,702,000 |
3 | Revenues | 3,766,000 |
4 | StockholdersEquity | 143,906,000 |
5 | NetIncome | -74,936,000 |
6 | ComprehensiveNetIncome | -74,951,500 |
7 | BaseVar | 130,915,500 |
8 | EconomicCapitalRatio | 1.92 |